Clinical Trial Detail

NCT ID NCT02974738
Title A Trial of PT2977 Tablets In Patients With Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Peloton Therapeutics, Inc.
Indications

Advanced Solid Tumor

clear cell renal cell carcinoma

Therapies

PT 2977

Age Groups: senior adult

No variant requirements are available.